Aligos Therapeutics
Stock Forecast, Prediction & Price Target
Aligos Therapeutics Financial Estimates
Aligos Therapeutics Revenue Estimates
Aligos Therapeutics EBITDA Estimates
Aligos Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $4.35M N/A | $13.90M 219.04% | $15.52M 11.66% | Avg: $25.40M Low: $25.40M High: $25.40M avg. 63.62% | Avg: $32.50M Low: $32.50M High: $32.50M avg. 27.91% | Avg: $122M Low: $122M High: $122M avg. 275.35% | Avg: $239.00M Low: $239.00M High: $239.00M avg. 95.90% |
Net Income
% change YoY
| $-128.33M N/A | $-96.04M 25.15% | $-87.67M 8.71% | Avg: $-119.58M Low: $-45.62M High: $-45.62M avg. -36.39% | Avg: $-145.21M Low: $-55.26M High: $-55.26M avg. -21.43% | Avg: $-68.75M Low: $-68.75M High: $-68.75M avg. 52.65% | Avg: $-2.57M Low: $-2.57M High: $-2.57M avg. 96.26% |
EBITDA
% change YoY
| $-128.32M N/A | $-97.58M 23.95% | $-85.05M 12.83% | Avg: $-5.08M Low: $-5.08M High: $-5.08M avg. 94.02% | Avg: $-6.50M Low: $-6.50M High: $-6.50M avg. -27.91% | Avg: $-24.39M Low: $-24.39M High: $-24.39M avg. -275.35% | Avg: $-47.80M Low: $-47.80M High: $-47.80M avg. -95.90% |
EPS
% change YoY
| -$3.22 N/A | -$2.25 30.12% | -$3.52 -56.44% | Avg: -$0.71 Low: -$0.71 High: -$0.71 avg. 79.82% | Avg: -$0.86 Low: -$0.86 High: -$0.86 avg. -21.12% | Avg: -$1.07 Low: -$1.07 High: -$1.07 avg. -24.41% | Avg: -$0.04 Low: -$0.04 High: -$0.04 avg. 96.26% |
Operating Expenses
% change YoY
| $132.68M N/A | $111.48M -15.97% | $103.65M -7.02% | Avg: $61.85M Low: $61.85M High: $61.85M avg. -40.32% | Avg: $79.12M Low: $79.12M High: $79.12M avg. 27.91% | Avg: $297.00M Low: $297.00M High: $297.00M avg. 275.35% | Avg: $581.85M Low: $581.85M High: $581.85M avg. 95.90% |
FAQ
What is Aligos Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 22.77% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -45.62M, average is -119.58M and high is -45.62M.
What is Aligos Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 115.70% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $25.40M, average is $25.40M and high is $25.40M.
What is Aligos Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 32.63% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.71, average is -$0.71 and high is $-0.71.